nucleus software q2 results: miss on all fronts | vishnu dusad | market fatafat | business news
Published 9 months ago • 739 plays • Length 16:47Download video MP4
Download video MP3
Similar videos
-
6:23
nucleus software: factors driving growth momentum | vishnu r dusad discuss | business news
-
12:41
exclusive: nucleus software's co-founder & md vishnu r dusad | nucleus software share |
-
6:31
nucleus software's vishnu r dusad exclusive on the firm's strong q3fy23 results | cnbc-tv18
-
7:19
have managed to take a price increase with 70-80% of their customers: nucleus software exports
-
5:46
haven’t seen concerns around re-pricing: nucleus software mgmt | cnbc tv18
-
8:14
watch our president and ceo pekka lundmark discuss nokia's q2 results with david mulholland
-
7:34
ev game-changer: zeekr's q2 financial results
-
21:17
nucleus software at cnbc tv18 banking transformation summit | mr. vishnu r. dusad & dr. ritika dusad
-
6:54
nucleus software: new deal in focus | vishnu r dusad shares insights with ajaya sharma
-
2:56
nucleus software q1 results 2023 🔴 nucleus software results 🔴 nucleus software share latest news
-
0:22
nucleus software exports shares rise 17% in early deals; why? #sebiregisteredanalyst #stockmarket
-
9:24
nucleus software's parag bhise exclusive on the firm's deal with bank of sydney & q2fy23 results
-
0:16
final trades: applied materials, nu holdings, the jepq and the iyj
-
1:31
skoda kylaq launch expected by february 2025: petr janeba, brand director, skoda india | cnbc tv18
-
0:51
nucleus software exports buyback 🤑 #shorts
-
10:15
vishnu r. dusad on nucleus software’s ambitious hiring plans: 300 new positions
-
2:32
nucleus software hits a fresh 52-week high | midcap radar | cnbc tv18
-
5:53
nucleus software q3 pat at rs 10.6 cr.vs.rs.11.45 cr
-
2:00
(18) nih confirms ucla findings: mr-us fusion biopsy better at detecting serious prostate cancers
-
1:10
‘mixed bag’: only a fraction of recent drug approvals in nsclc space ‘considered practice changing’
-
21:07
bhaskar rao retirement symposium - power optimization and semi blind channel estimation-elina nayebi
-
2:22
sabcs: mixed results for targeted agents in breast ca